Association of genetic polymorphisms and their attributing factors with lipid profiles among outpatient statin users in Hospital USM
Statins, or 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors, are routinely used to lower lipid levels primarily low-density lipoprotein cholesterol (LDL-c). Treatment guidelines recommend LDL-c as the primary target of therapy in hyperlipidaemic patients. Inter-individual variat...
| المؤلف الرئيسي: | |
|---|---|
| التنسيق: | أطروحة |
| اللغة: | الإنجليزية |
| منشور في: |
2022
|
| الموضوعات: | |
| الوصول للمادة أونلاين: | http://eprints.usm.my/57319/ |
| Abstract | Abstract here |
